News Sanofi buys Provention and diabetes drug Tzield for $2.9bn T1D prevention drug has been tipped as a blockbuster, boosting Sanofi's diabetes franchise.
News Sanofi sings a song for rare disease and equitable care 'This is Rare' campaign sings the plight of the rare disease community this awareness day.
News Sanofi boosts ‘connected insulin’ push with Glooko deal The alliance will pair Glooko's digital health platform with Sanofi's SoloSmart insulin device.
News Sanofi gets FDA nod for long-acting haemophilia A drug Once-weekly Altuviiio could be potential $2 billion-plus blockbuster, according to analysts.
News Reed pops up at J&J after leaving Sanofi Straight after John Reed's Sanofi exit, he has reappeared as head of pharma R&D at J&J
News Sanofi reveals R&D leadership shake-up Change is afoot at the helm of international pharma company Sanofi, as it announces the departure of a key leadership figure from its research and development team.
News Beren's Niemann-Pick drug Lembaz cleared by FDA The FDA has approved Beren's Lembaz for Niemann-Pick disease type C, the first drug shown to extend survival in the ultra-rare inherited disorder.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.